Poly Medicure: The financial results for the period ended September 30, 2026
Poly Medicure (POLYMED) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹16,114 crore.
What happened
Poly Medicure (POLYMED) filed a disclosure with the exchanges on 5 November 2026 at 02:15 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Poly Medicure is a small-cap company in the Healthcare sector, with a market value of about ₹16,114 crore.
The stock last traded at ₹1,589.8, against a 52-week range of ₹1,182–₹2,094.3 (24.1% below the high).
Before this filing the shares had moved −8.7% over the month and −13.2% over three months. Average daily turnover over the last 20 sessions was about ₹11.94 crore.
Promoters held 62.42% at the end of Q1 FY27. Foreign institutions owned 5.57% and domestic institutions 16.08%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 403 | 93.1 | 9.19 |
| Q2 FY26 | 444 | 91.8 | 9.06 |
| Q3 FY26 | 494 | 70.9 | 7 |
| Q4 FY26 | 535 | 66.3 | 6.54 |
| Q1 FY27 | 525 | 86 | 8.49 |
What history shows
This is not the company's first results disclosure: BCEIE has 4 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 9.6% on average the next trading day and was down 9.8% on average after five days (4 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +2.0% over five days; 57% of them rose the next day.
Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 7 Aug 2026 | Standalone & Consolidated Unaudited Financial Results For The… | +3.7% | +4.5% |
| 25 May 2026 | Declaration Of Unmodified Opinion On The Audited Financial… | −14.0% | −14.6% |
| 25 May 2026 | Audited Financial Results (Standalone & Consolidated) For The… | −14.0% | −14.6% |
| 25 May 2026 | Board Meeting Outcome for Poly Medicure Limited Has Submitted To The… | −14.0% | −14.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.